Zika Virus: Pharma’s New Cash Cow!

Wednesday, April 27, 2016
By Paul Martin

Christopher Wyatt
April 26, 2016

Anyone who who has watched the news as of late has heard of the Zika virus and all its dangers. Why is this? Could it be because they are working on a vaccine? On Tuesday April 19th, 2016 President Obama signed S. 2512, the “Adding Zika Virus to the FDA Priority Review Voucher Program Act” which allows for this vaccine to be fast tracked and a vaccine trial ready for September of 2016.

Check out the article below to see why this is a cash cow for vaccine makers.

by GEN News Highlights

Protein Sciences, Sinergium Partner with Foundation to Develop Zika Vaccine

“Protein Sciences, Sinergium Biotech, and the private foundation Mundo Sano said today they will form a consortium to jointly develop a vaccine against the Zika virus.

The value of the collaboration was not disclosed. Sinergium agreed to pay an upfront fee to fund development and manufacture of the vaccine being produced at Protein Sciences. The vaccine will be produced using the technology of Protein Sciences, whose FDA-approved Flublok is the world’s first recombinant protein-based vaccine for prevention of seasonal influenza disease.

In return, Sinergium will receive manufacturing and commercial rights to the vaccine in Argentina and other counties to be determined. The companies also said they are in “active” discussions with additional strategic partners worldwide, with the goal of strengthening and rapidly advancing the development program.

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter